oncolytic viruses
Tune Up In Situ Autovaccination against Solid Tumors with Oncolytic Viruses
31
Non Linear Mathematical Model of the Interaction between Tumor and Oncolytic Viruses
8
Mathematical modeling of tumor therapy with oncolytic viruses: effects of parametric heterogeneity on cell dynamics
19
Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
13
Dynamics of a mathematical model for cancer therapy with oncolytic viruses
12
New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy
18
Immune cells: more than simple carriers for systemic delivery of oncolytic viruses
9
Oncolytic viruses as immunotherapy: progress and remaining challenges
11
The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses
11
Combination Vascular Delivery of Herpes Simplex Oncolytic Viruses and Amplicon Mediated Cytokine Gene Transfer Is Effective Therapy for Experimental Liver Cancer
8
Potential of oncolytic viruses in the treatment of multiple myeloma
12
Cell carriers for oncolytic viruses: current challenges and future directions
10
Perspectives on immunotherapy via oncolytic viruses
8
Prospects for combined use of oncolytic viruses and CAR T-cells
27
Oncolytic Viruses for the Treatment of Cancer (A review)
14
The ex vivo purge of cancer cells using oncolytic viruses: recent advances and clinical implications
11
Oncolytic viruses: overcoming translational challenges
13
Oncoselectivity in Oncolytic Viruses against Colorectal Cancer
23
Targeting Human Glioblastoma Cells: Comparison of Nine Viruses with Oncolytic Potential
18
Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in V600D/E BRAF mutant melanoma depends on JNK and TNF-α signaling
39